Target intelligence / Profile preview

Human Islet Amyloid Polypeptide Oligomer

Molecular classification
Peptide, Amyloid Oligomer
01

Overview

Human islet amyloid polypeptide (hIAPP) oligomers are soluble, aggregated forms of the 37-residue peptide hormone hIAPP/amylin. These oligomers are implicated in the pathogenesis of type 2 diabetes mellitus (T2D) due to their toxicity to pancreatic β-cells. They disrupt cell membranes, induce apoptosis, and interfere with insulin secretion. The core region responsible for aggregation lies within residues 20–29. Metal ions, particularly Cu(II), can influence the oligomerization pathway and increase toxicity.

Other names
hIAPP OligomerAmylin OligomerIAPP OligomersSoluble IAPP Oligomers
02

Mechanism of action

Disruption of cell membranes, leading to increased permeability and/or direct lysis, particularly in pancreatic β-cells, ultimately triggering apoptosis.

03

Biological functions

Membrane disruptionApoptosis inductionDisruption of cell-cell adherenceImpaired insulin secretion
04

Disease associations

Type 2 Diabetes MellitusIslet Transplantation Failure
05

Safety considerations

Off-target effects due to membrane disruptionPotential for exacerbating β-cell dysfunction if not specifically targeted

Beyond the preview

Go deeper on Human Islet Amyloid Polypeptide Oligomer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Islet Amyloid Polypeptide Oligomer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call